SCHEMBL2509397

SCHEMBL2509397

CCCCN1Cc2cc(Nc3cncc(Cl)c3)ccc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.44
PRF1 P14222 4/20 0.38
CYP11B2 P19099 3/20 0.38
GRM5 P41594 1/20 0.37
CCR2 P41597 1/20 0.35
CRBN Q96SW2 1/20 0.35
DRD2 P14416 1/20 0.35
DRD5 P21918 1/20 0.35
DRD3 P35462 1/20 0.35
MET P08581 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRA6 Q16445 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2508327 0.85 HDAC6 (0.44) HDAC6PRF1GRM5ALDH1A1IDH1
SCHEMBL2504281 0.84 HDAC6 (0.42) HDAC6PRF1CYP11B2GRM5CCR2
SCHEMBL2509389 0.81 PIK3CA (0.44) HDAC6PRF1GRM5CCR2DRD2
SCHEMBL2509330 0.81 HDAC6 (0.40) HDAC6PRF1DRD2DRD5DRD3
SCHEMBL2504269 0.78 HDAC6 (0.44) HDAC6GRM5IDH1
SCHEMBL2505866 0.77 HDAC6 (0.45) HDAC6PRF1GRM5CCR2MKNK1
SCHEMBL2505706 0.76 HDAC6 (0.42) HDAC6PRF1GRM5ALDH1A1IDH1
SCHEMBL2503427 0.75 HDAC6 (0.43) HDAC6PRF1GRM5ALDH1A1MAPK1
SCHEMBL2505984 0.75 HDAC6 (0.40) HDAC6CCR2DRD2DRD5DRD3
SCHEMBL2505981 0.74 HDAC6 (0.44) HDAC6PRF1GRM5MKNK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314120-B2 Small molecule potentiators of metabotropic glutamate receptors ABBOTT GMBH & CO. KG (DE) 2012-11-20 US claimed
US-8314120-B2 Small molecule potentiators of metabotropic glutamate receptors ABBOTT GMBH & CO. KG (DE) 2012-11-20 US disclosed
US-20110245247-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS ABBOTT GMBH & CO. KG (DE) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245247-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRIN2C, GRM3, GRM2 HDAC6 2622/4885PRF1 4486/4885CYP11B2 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.